NDC properties for NDC 9 49502-380
NDC item 49502038002
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-02 |
| NDC Item | 49502038002 |
| packaging | 2 TRAY in 1 KIT (49502-380-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-540-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-542-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-06-30 |
| Marketing effective time low | 2023-07-01 |
| Marketing status | COMPLETED |
NDC item 49502038006
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-06 |
| NDC Item | 49502038006 |
| BLA | BLA761154 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-06-30 |
| Marketing effective time low | 2023-07-01 |
| Marketing status | COMPLETED |
NDC item 83257001932
| NDC 9 | 83257-019 |
|---|---|
| NDC 10 | 83257-019-32 |
| NDC Item | 83257001932 |
| packaging | 2 TRAY in 1 KIT (83257-019-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |